Navigation Links
MKM Partners Hires Biotechnology/Specialty Pharmaceuticals Analyst
Date:6/13/2011

STAMFORD, Conn., June 13, 2011 /PRNewswire/ -- MKM Partners today announced that Jon LeCroy, M.D., has joined as a Managing Director in its Equity Research department to cover biotechnology and specialty pharmaceuticals companies, inaugurating MKM's research expansion into the healthcare sector.

Dr. LeCroy covered the same sector at Hapoalim Securities USA most recently and at Natixis Bleichroeder and Goldman Sachs before that. He ranked #5 in this year's Wall Street Journal Best on the Street poll in Biotechnology. Dr. LeCroy holds an MBA from Boston University's Graduate School of Management, an M.D. from University of South Florida College of Medicine and a B.S. in biology from Wake Forest University. He will be based in MKM's Stamford headquarters.

"I am excited about the opportunity to join MKM Partners and plan to build on the firm's previous success by expanding research coverage into the healthcare industry," Jon remarked.

"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research – and his stockpicking prowess – will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."

ABOUT MKM PARTNERS

MKM Partners is an institutional equity research, sales and trading firm. Headquartered in Stamford, Connecticut, with offices in New York City, Boston and across the U.S., MKM provides clients with actionable and unbiased economic, technical, derivatives, event-driven and fundamental research and has trade execution abilities in U.S. and foreign equity markets and in U.S. options markets. In addition to offering timely access to its traders and analysts, MKM focuses on delivering exceptional service to institutional clients across its trading and research platforms. More information about MKM Partners can be accessed at www.mkmpartners.com.

For more information, contact:

Richard R. Castellano, CEO

(203) 861-9060


'/>"/>
SOURCE MKM Partners
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Announces Innovative Partnership With University of Pittsburgh Biomedical Engineering Society
2. Pfizer Inc. and PAREXEL International Corp. Sign Strategic Partnership Agreement to Advance Clinical Development
3. Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students
4. Jennerex and Partners Present Positive JX-594 Randomized Phase 2 Clinical Data Showing Promising Survival Benefit in Patients with Advanced Liver Cancer
5. Rules-Based Medicine, Inc. (RBM) Partners with Institut Pasteur to Boost Innovation in Translational Research
6. Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis
7. John McKearn, Ph.D., Promoted to Managing Director of RiverVest Venture Partners
8. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
9. Omnicare Clinical Research Acquired by Nautic Partners, LLC
10. CBI Announces Partnership With Childrens Rare Disease Network and The Global Genes Project
11. Lifeline Skin Care™ Selects Click Here, Inc., Richards Partners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ... host a live webcast of its Annual Meeting of Shareholders on ... The webcast can be accessed from the BD corporate website at ... 31, 2017. ... About BD BD is a global medical technology company that ...
(Date:1/18/2017)... to a new market research report "In situ Hybridization Market by Technique (FISH, ... Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published by MarketsandMarkets, ... 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... Logo ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017 ... applying mechanistic modeling to drug research and development, ... PhD, Co-Founder, President, and CEO of Applied BioMath, ... for Informatics and Modeling (BAGIM) Meeting on Thursday ... Cambridge , MA.   Dr. Burke,s ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... Executives 2017 in its continued commitment to the advancement of the clinical trials ... current issues related to clinical trial planning and management. , As executive ...
Breaking Biology Technology:
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
(Date:1/4/2017)... Jan. 4, 2017  CES 2017 – Valencell ... technology, today announced the launch of two new ... the highly-accurate biometric sensor modules that incorporate the ... experience and expertise. The two new designs include ... for hearables, and Benchmark BW2.0, a 2-LED version ...
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
Breaking Biology News(10 mins):